A commentary review on endoscopic sleeve gastroplasty: Indications, outcomes and future implications.
bariatric
diabetes
endoscopic sleeve gastrectomy
obesity
Journal
Diabetes, obesity & metabolism
ISSN: 1463-1326
Titre abrégé: Diabetes Obes Metab
Pays: England
ID NLM: 100883645
Informations de publication
Date de publication:
29 Apr 2024
29 Apr 2024
Historique:
revised:
08
04
2024
received:
07
02
2024
accepted:
09
04
2024
medline:
30
4
2024
pubmed:
30
4
2024
entrez:
30
4
2024
Statut:
aheadofprint
Résumé
Metabolic and bariatric surgeries have been shown to be the most effective strategy to induce and maintain significant weight loss for people living with severe obesity. However, ongoing concerns regarding operative risks, irreversibility and excess costs limit their broader clinical use. Endoscopic bariatric therapies are pragmatic alternatives for patients who are not suitable for metabolic and bariatric surgeries or who are concerned regarding their long-term safety. Endoscopic sleeve gastroplasty has emerged as a novel technique of endoscopic bariatric therapies, which have garnered significant interest and evidence in the past few years. Its safety, efficacy and cost-effectiveness have been shown in various studies, while comparisons with sleeve gastrectomy have been widely made. This review brings together current evidence pertaining to the technicality of the procedure itself, current indications, safety and efficacy, cost-effectiveness, as well as its future role and development.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 John Wiley & Sons Ltd.
Références
Angrisani L, Santonicola A, Iovino P, Formisano G, Buchwald H, Scopinaro N. Bariatric surgery worldwide 2013. Obes Surg. 2015;25(10):1822‐1832.
Welbourn R, Hollyman M, Kinsman R, et al. Bariatric surgery worldwide: baseline demographic description and one‐year outcomes from the fourth IFSO global registry report 2018. Obes Surg. 2019;29(3):782‐795.
Shahabi S, Parmar C, Yang W, et al. Bariatric and metabolic surgery in patients with low body mass index: an online survey of 543 bariatric and metabolic surgeons. BMC Surg. 2023;23(1). doi:10.1186/s12893‐023‐02175‐4
Mohamed BKI, Barajas‐Gamboa JS, Rodriguez J. Endoscopic bariatric therapies: current status and future perspectives. JSLS. 2022;26(1):e2021.00066. doi:10.4293/jsls.2021.00066
Abu Dayyeh BK, Rajan E, Gostout CJ. Endoscopic sleeve gastroplasty: a potential endoscopic alternative to surgical sleeve gastrectomy for treatment of obesity. Gastrointest Endosc. 2013;78(3):530‐535.
https://www.nice.org.uk/guidance/indevelopment/gid-ipg10300 Endoscopic sleeve gastroplasty for obesity In development [GID‐IPG10300]Expected publication date: 22 February 2024.
López‐Nava G, Sharaiha RZ, Vargas EJ, et al. Endoscopic sleeve gastroplasty for obesity: a multicenter study of 248 patients with 24 months follow‐up. Obes Surg. 2017b;27(10):2649‐2655. doi:10.1007/s11695‐017‐2693‐7
Barola S, Chen Y, Ngamruengphong S, Kalloo AN, Khashab MA, Kumbhari V. Technical aspects of endoscopic sleeve gastroplasty. Gastrointest Endosc. 2017;85(4):862. doi:10.1016/j.gie.2017.02.012
Qureshi H, Saeed N, Jovani M. Updates in endoscopic bariatric and metabolic therapies. J Clin Med. 2023;12(3):1126. doi:10.3390/jcm12031126
Mauro A, Lusetti F, Scalvini D, et al. A comprehensive review on bariatric endoscopy: where we are now and where we are going. Medicina‐Lithuania. 2023;59(3):636. doi:10.3390/medicina59030636
Espinós J, Turró R, Mata A, et al. Early experience with the incisionless operating PlatformTM (IOP) for the treatment of obesity. Obes Surg. 2013;23(9):1375‐1383. doi:10.1007/s11695‐013‐0937‐8
Gys B, Plaeke P, Lamme B, et al. Endoscopic gastric plication for morbid obesity: a systematic review and meta‐analysis of published data over time. Obes Surg. 2019;29(9):3021‐3029. doi:10.1007/s11695‐019‐04010‐3
Abu Dayyeh BK, Acosta A, Camilleri M, et al. Endoscopic sleeve gastroplasty alters gastric physiology and induces loss of body weight in obese individuals. Clin Gastroenterol Hepatol. 2017;15(1):37‐43 e1.
Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet‐induced weight loss or gastric bypass surgery. N Engl J Med. 2002;346(21):1623‐1630.
Holdstock C, Engström BÉ, Öhrvall M, Lind L, Sundbom M, Karlsson FA. Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans. J Clin Endocrinol Metab. 2003;88(7):3177‐3183.
Faraj M, Havel PJ, Phélis S, Blank D, Sniderman AD, Cianflone K. Plasma acylation‐stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab. 2003;88(4):1594‐1602.
Li JV, Ashrafian H, Bueter M, et al. Metabolic surgery profoundly influences gut microbial‐host metabolic cross‐talk. Gut. 2011;60(9):1214‐1223.
Furet JP, Kong LC, Tap J, et al. Differential adaptation of human gut microbiota to bariatric surgery‐induced weight loss: links with metabolic and low‐grade inflammation markers. Diabetes. 2010;59(12):3049‐3057.
Brighton CA, Rievaj J, Kuhre RE, et al. Bile acids trigger GLP‐1 release predominantly by accessing Basolaterally located G protein‐coupled bile acid receptors. Endocrinology. 2015;156(11):3961‐3970.
Lorenzo‐Zuniga V et al. Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats. Hepatology. 2003;37(3):551‐557.
Kohli R, Bradley D, Setchell KD, Eagon JC, Abumrad N, Klein S. Weight loss induced by Roux‐en‐Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids. J Clin Endocrinol Metab. 2013;98(4):E708‐E712.
Steinert RE, Peterli R, Keller S, et al. Bile acids and gut peptide secretion after bariatric surgery: a 1‐year prospective randomized pilot trial. Obesity (Silver Spring). 2013;21(12):E660‐E668.
Holt JA, Luo G, Billin AN, et al. Definition of a novel growth factor‐dependent signal cascade for the suppression of bile acid biosynthesis. Genes Dev. 2003;17(13):1581‐1591.
Sarkar A, Tawadros A, Andalib I, et al. Safety and efficacy of endoscopic sleeve gastroplasty for obesity management in new bariatric endoscopy programs: a multicenter international study. Ther Adv Gastrointest Endosc. 2022;15:263177452210938. doi:10.1177/26317745221093883
Eisenberg D, Shikora SA, Aarts EO, et al. 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of obesity and metabolic disorders (IFSO): indications for metabolic and bariatric surgery. Surg Obes Relat Dis. 2022;18(12):1345‐1356. doi:10.1016/j.soard.2022.08.013
Mechanics JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient – 2013 update: cosponsored by the American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & bariatric surgery. Surg Obes Relat Dis. 2013;9:159‐191.
Neto MG, Silva LB, de Quadros LG, et al. Brazilian consensus on endoscopic sleeve gastroplasty. Obes Surg. 2021;31(1):70‐78.
Beran A, Matar R, Jaruvongvanich V, et al. Comparative effectiveness, and safety between endoscopic sleeve gastroplasty and laparoscopic sleeve gastrectomy: a meta‐analysis of 6775 individuals with obesity. Obes Surg. 2022;32(11):3504‐3512.
Abu Dayyeh BK, Bazerbachi F, Vargas EJ, et al. Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial. Lancet. 2022;400(10350):441‐451.
Neto MG, Moon RC, de Quadros LG, et al. Safety and short‐term effectiveness of endoscopic sleeve gastroplasty using overstitch: preliminary report from a multicenter study. Surg Endosc. 2020;34(10):4388‐4394.
Fayad L, Adam A, Schweitzer M, et al. Endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy: a case‐matched study. Gastrointest Endosc. 2019;89(4):782‐788.
Hedjoudje A, Abu Dayyeh BK, Cheskin LJ, et al. Efficacy and safety of endoscopic sleeve gastroplasty: a systematic review and meta‐analysis. Clin Gastroenterol Hepatol. 2020;18(5):1043‐1053.e4.
Alqahtani AR, Elahmedi M, Alqahtani YA, Al‐Darwish A. Endoscopic sleeve gastroplasty in 109 consecutive children and adolescents with obesity: two‐year outcomes of a new modality. Am J Gastroenterol. 2019;114(12):1857‐1862. doi:10.14309/ajg.0000000000000440
Beamish AJ, Harper ER, Järvholm K, Janson A, Olbers T. Long‐term outcomes following adolescent metabolic and bariatric surgery. J Clin Endocrinol Metabol. 2023;108(9):2184‐2192. doi:10.1210/clinem/dgad155
Goyal H, Kopel J, Perisetti A, et al. Endobariatric procedures for obesity: clinical indications and available options. Ther Adv Gastrointest Endosc. 2021;14, 263177452098462. doi:10.1177/2631774520984627
Docimo S, Aylward L, Albaugh VL, Afaneh C. Endoscopic sleeve gastroplasty and its role in the treatment of obesity: a systematic review. Surg Obes Relat Dis. 2023;19:1205‐1218.
Alqahtani AR, Elahmedi M, Al‐Darwish A, Abdurabu HY, Alqahtani S. Endoscopic gastroplasty versus laparoscopic sleeve gastrectomy: a noninferiority propensity score–matched comparative study. Gastrointest Endosc. 2022;96(1):44‐50. doi:10.1016/j.gie.2022.02.050
James TW, McGowan CE. The descending gastric fundus in endoscopic sleeve gastroplasty: implications for procedural technique and adverse events. VideoGIE. 2019b;4(6):254‐255. doi:10.1016/j.vgie.2019.03.009
Hill C, Zein ME, Agnihotri A, et al. Endoscopic sleeve gastroplasty: the learning curve. Endosc Int Open. 2017;05(09):E900‐E904. doi:10.1055/s‐0043‐115387
Matteo MV, Bove VM, Pontecorvi V, et al. Outcomes of endoscopic sleeve gastroplasty in the elder population. Obes Surg. 2022;32(10):3390‐3397. doi:10.1007/s11695‐022‐06232‐4
Fehervari M, Fadel MG, Alghazawi LOK, et al. Medium‐term weight loss and remission of comorbidities following endoscopic sleeve gastroplasty: a systematic review and meta‐analysis. Obes Surg. 2023;33(11):3527‐3538. doi:10.1007/s11695‐023‐06778‐x
Sharaiha RZ, Hajifathalian K, Kumar RB, et al. Five‐year outcomes of endoscopic sleeve gastroplasty for the treatment of obesity. Clin Gastroenterol Hepatol. 2021;19(5):1051‐1057.e2. doi:10.1016/j.cgh.2020.09.055
Sharaiha RZ, Kumta NA, Saumoy M, et al. Endoscopic sleeve gastroplasty significantly reduces body mass index and metabolic complications in obese patients. Clin Gastroenterol Hepatol. 2017 Apr;15(4):504‐510.
Wing RR, Lang W, Wadden TA, et al. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care. 2011;34(7):1481‐1486.
Pizzicannella M, Fiorillo C, Barberio M, et al. Endoscopic assessment of morphological and histopathological upper gastrointestinal changes after endoscopic sleeve gastroplasty. Surg Obes Relat Dis. 2021;17(7):1294‐1301.
Alqahtani AR, Al‐Darwish A, Mahmoud AE, Alqahtani YA, Elahmedi M. Short‐term outcomes of endoscopic sleeve gastroplasty in 1000 consecutive patients. Gastrointest Endosc. 2019;89(6):1132‐1138. doi:10.1016/j.gie.2018.12.012
Hajifathalian K, Sharaiha RZ, Ang B, et al. Long‐term follow‐up and outcomes after endoscopic sleeve gastroplasty for treatment of obesity (5‐year data). Gastrointest Endosc. 2019;89:AB58.
Wang J, Chen C. Current status of endoscopic sleeve gastroplasty: an opinion review. World J Gastroenterol. 2020;26(11):1107‐1112. doi:10.3748/wjg.v26.i11.1107
Nduma BN, Mofor KA, Tatang J, et al. Endoscopic sleeve gastroplasty (ESG) versus laparoscopic sleeve gastroplasty (LSG): a comparative review. Cureus. 2023;15. doi:10.7759/cureus.41466
Himpens J, Dobbeleir JM, Peeters G. Long‐term results of laparoscopic sleeve gastrectomy for obesity. Ann Surg. 2010;252(2):319‐324. doi:10.1097/sla.0b013e3181e90b31
Fayad L, Schweitzer M, Itani MI, et al. Does endoscopic mean safer? A comparison of the short‐term safety of endoscopic versus laparoscopic bariatric therapies. Endosc Int Open. 2022;10(04):E307‐E310. doi:10.1055/a‐1783‐8573
Fiorillo C, Quero G, Vix M, et al. 6‐month gastrointestinal quality of life (QoL) results after endoscopic sleeve gastroplasty and laparoscopic sleeve gastrectomy: a propensity score analysis. Obes Surg. 2020;30(5):1944‐1951.
Kermansaravi M, Parmar C, Chiappetta S, et al. Best practice approach for redo‐surgeries after sleeve gastrectomy, an expert's modified Delphi consensus. Surg Endosc. 2023b;37(3):1617‐1628. doi:10.1007/s00464‐023‐09879‐x
Maselli DB, Alqahtani AR, Dayyeh BKA, et al. Revisional endoscopic sleeve gastroplasty of laparoscopic sleeve gastrectomy: an international, multicenter study. Gastrointest Endosc (Print). 2021b;93(1):122‐130. doi:10.1016/j.gie.2020.05.028
Ghoz H, Bryant M, Fritz H, et al. Endoscopic sleeve gastroplasty and postprocedural nutritional deficiencies: results from a single centre exploratory study. Eur J Gastroenterol Hepatol. 2021;33(1S):e1039‐e1041. doi:10.1097/meg.0000000000002316
Kelly J, Menon V, O'Neill F, et al. UK cost‐effectiveness analysis of endoscopic sleeve gastroplasty versus lifestyle modification alone for adults with class II obesity. Int J Obes (Lond). 2023;47:1161‐1170.
Ferrer‐Marquez M, Ferrer‐Ayza M, Rubio‐Gil F, et al. Revision bariatric surgery after endoscopic sleeve gastroplasty. Cir Cir. 2017;85(5):428‐431.
Movitz BR, Lutfi RE. Endoscopic sleeve gastroplasty: are we burning bridges? Surg Obes Relat Dis. 2017;13(12):2056‐2058.
Saumoy M, Schneider Y, Zhou XK, et al. A single‐operator learning curve analysis for the endoscopic sleeve gastroplasty. Gastrointest Endosc. 2018;87(2):442‐447.
Wilding JP, Batterham RL, Calanna S, et al. Once weekly semaglutide in adults with Overwieght or obesity 2021. N Engl J Med. 2021;384(11):989‐1002. doi:10.1056/NEJMoa2032183
Aronne LJ, Sattar N, Horn DB, et al. Continued treatment with Tirzepatide for maintenance of weight reduction in adults with obesity. The SURMOUNT‐4 randomised clinical trial. Jama. 2024;331:38‐48.